{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T15:24:33Z","timestamp":1774538673452,"version":"3.50.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,8,14]],"date-time":"2021-08-14T00:00:00Z","timestamp":1628899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,8,14]],"date-time":"2021-08-14T00:00:00Z","timestamp":1628899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2016\/25615-6"],"award-info":[{"award-number":["2016\/25615-6"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s12026-021-09225-0","type":"journal-article","created":{"date-parts":[[2021,8,14]],"date-time":"2021-08-14T06:02:50Z","timestamp":1628920970000},"page":"445-456","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Phenotypes of STAT3 gain-of-function variant related to disruptive regulation of CXCL8\/STAT3, KIT\/STAT3, and IL-2\/CD25\/Treg axes"],"prefix":"10.1007","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2053-2827","authenticated-orcid":false,"given":"Lia Furlaneto","family":"Marega","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janine Schincariol","family":"Sabino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcus Vinicius","family":"Pedroni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcelo","family":"Teocchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina","family":"Lanaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dulcin\u00e9ia Martins","family":"de Albuquerque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene Pereira","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando Ferreira","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2618-0148","authenticated-orcid":false,"given":"Maria Marluce","family":"dos Santos Vilela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,8,14]]},"reference":[{"issue":"7","key":"9225_CR1","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s10875-015-0187-8","volume":"35","author":"TP Vogel","year":"2015","unstructured":"Vogel TP, Milner JD, Cooper MA. The ying and yang of STAT3 in human disease. J Clin Immunol. 2015;35(7):615\u201323. https:\/\/doi.org\/10.1007\/s10875-015-0187-8.","journal-title":"J Clin Immunol"},{"issue":"6","key":"9225_CR2","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.3390\/ijms19061591","volume":"19","author":"J Sgrignani","year":"2018","unstructured":"Sgrignani J, Garofalo M, Matkovic M, Merulla J, Catapano CV, Cavalli A. Structural biology of STAT3 and its implications for anticancer therapies development. Int J Mol Sci. 2018;19(6):1591. https:\/\/doi.org\/10.3390\/ijms19061591.","journal-title":"Int J Mol Sci"},{"key":"9225_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2019.108316","volume":"210","author":"S J\u00e4gle","year":"2020","unstructured":"J\u00e4gle S, Heeg M, Gr\u00fcn S, et al. Distinct molecular response patterns of activating STAT3 mutations associate with penetrance of lymphoproliferation and autoimmunity. Clin Immunol. 2020;210: 108316. https:\/\/doi.org\/10.1016\/j.clim.2019.108316.","journal-title":"Clin Immunol"},{"issue":"1","key":"9225_CR4","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/MOH.0000000000000206","volume":"23","author":"LR Forbes","year":"2016","unstructured":"Forbes LR, Milner J, Haddad E. Signal transducer and activator of transcription 3: a year in review. Curr Opin Hematol. 2016;23(1):23\u20137. https:\/\/doi.org\/10.1097\/MOH.0000000000000206.","journal-title":"Curr Opin Hematol"},{"key":"9225_CR5","doi-asserted-by":"publisher","first-page":"168","DOI":"10.3389\/fimmu.2018.00168","volume":"9","author":"EK Deenick","year":"2018","unstructured":"Deenick EK, Pelham SJ, Kane A, Ma CS. Signal transducer and activator of transcription 3 control of human T and B cell responses. Front Immunol. 2018;9:168. https:\/\/doi.org\/10.3389\/fimmu.2018.00168.","journal-title":"Front Immunol"},{"issue":"1","key":"9225_CR6","doi-asserted-by":"publisher","first-page":"e20180160","DOI":"10.1590\/1678-4685-GMB-2018-0160","volume":"43","author":"S Arshad","year":"2020","unstructured":"Arshad S, Naveed M, Ullia M, Javed K, Butt A, Khawar M, Amjad F. Targeting STAT-3 signaling pathway in cancer for development of novel drugs: advancements and challenges. Genet Mol Biol. 2020;43(1):e20180160. https:\/\/doi.org\/10.1590\/1678-4685-GMB-2018-0160.","journal-title":"Genet Mol Biol"},{"issue":"1","key":"9225_CR7","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1124\/mi.11.1.4","volume":"11","author":"PA Johnston","year":"2011","unstructured":"Johnston PA, Grandis JR. STAT3 signaling: anticancer strategies and challenges. Mol Interv. 2011;11(1):18\u201326. https:\/\/doi.org\/10.1124\/mi.11.1.4.","journal-title":"Mol Interv"},{"issue":"2","key":"9225_CR8","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.bbcan.2013.12.005","volume":"1845","author":"KS Siveen","year":"2014","unstructured":"Siveen KS, Sikka S, Surana R, et al. Targeting the STAT3 signaling pathway in cancer: role of synthetic and natural inhibitors. Biochim Biophys Acta. 2014;1845(2):136\u201354. https:\/\/doi.org\/10.1016\/j.bbcan.2013.12.005.","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"9225_CR9","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1016\/j.jaip.2019.02.018","volume":"7","author":"A Fabre","year":"2019","unstructured":"Fabre A, Marchal S, Barlogis V, et al. Clinical aspects of STAT3 gain-of-function germline mutations: a systematic review. J Allergy Clin Immunol Pract. 2019;7(6):1958-1969.e9. https:\/\/doi.org\/10.1016\/j.jaip.2019.02.018.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"9225_CR10","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1182\/blood-2014-04-570101","volume":"125","author":"EM Haapaniemi","year":"2015","unstructured":"Haapaniemi EM, Kaustio M, Rajala HL, et al. Autoimmunity, hypogammaglobulinemia, lymphoproliferation, and mycobacterial disease in patients with activating mutations in STAT3. Blood. 2015;125(4):639\u201348. https:\/\/doi.org\/10.1182\/blood-2014-04-570101.","journal-title":"Blood"},{"issue":"4","key":"9225_CR11","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1182\/blood-2014-09-602763","volume":"125","author":"JD Milner","year":"2015","unstructured":"Milner JD, Vogel TP, Forbes L, et al. Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations. Blood. 2015;125(4):591\u20139. https:\/\/doi.org\/10.1182\/blood-2014-09-602763.","journal-title":"Blood"},{"key":"9225_CR12","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.clim.2017.05.021","volume":"181","author":"S Nabhani","year":"2017","unstructured":"Nabhani S, Schipp C, Miskin H, et al. STAT3 gain-of-function mutations associated with autoimmune lymphoproliferative syndrome like disease deregulate lymphocyte apoptosis and can be targeted by BH3 mimetic compounds. Clin Immunol. 2017;181:32\u201342. https:\/\/doi.org\/10.1016\/j.clim.2017.05.021.","journal-title":"Clin Immunol"},{"key":"9225_CR13","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s10875-019-00737-x","volume":"40","author":"SG Tangye","year":"2020","unstructured":"Tangye SG, Al-Herz W, Bousfiha A, et al. Human inborn errors of immunity: 2019 update on the classification from the International Union of Immunological Societies Expert Committee. J Clin Immunol. 2020;40:24\u201364. https:\/\/doi.org\/10.1007\/s10875-019-00737-x.","journal-title":"J Clin Immunol"},{"issue":"2","key":"9225_CR14","doi-asserted-by":"publisher","first-page":"e30619","DOI":"10.1371\/journal.pone.0030619","volume":"7","author":"RK Patel","year":"2012","unstructured":"Patel RK, Jain M. NGS QC Toolkit: a toolkit for quality control of next generation sequencing data. PLoS One. 2012;7(2):e30619. https:\/\/doi.org\/10.1371\/journal.pone.0030619.","journal-title":"PLoS One"},{"issue":"14","key":"9225_CR15","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics . 2009;25(14):1754\u201360. https:\/\/doi.org\/10.1093\/bioinformatics\/btp324.","journal-title":"Bioinformatics"},{"key":"9225_CR16","doi-asserted-by":"publisher","first-page":"research0034.1","DOI":"10.1186\/gb-2002-3-7-research0034","volume":"3","author":"J Vandesompele","year":"2002","unstructured":"Vandesompele J, De Preter K, Pattyn F, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002;3:research0034.1. https:\/\/doi.org\/10.1186\/gb-2002-3-7-research0034.","journal-title":"Genome Biol"},{"issue":"4","key":"9225_CR17","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/ni.3691","volume":"18","author":"AV Villarino","year":"2017","unstructured":"Villarino AV, Kanno Y, O\u2019Shea JJ. Mechanisms and consequences of Jak-STAT signaling in the immune system. Nat Immunol. 2017;18(4):374\u201384. https:\/\/doi.org\/10.1038\/ni.3691.","journal-title":"Nat Immunol"},{"issue":"23","key":"9225_CR18","doi-asserted-by":"publisher","first-page":"8150","DOI":"10.1073\/pnas.0501643102","volume":"102","author":"L Liu","year":"2005","unstructured":"Liu L, McBride KM, Reich NC. STAT3 nuclear import is independent of tyrosine phosphorylation and mediated by importin-alpha3. Proc Natl Acad Sci U S A. 2005;102(23):8150\u20135. https:\/\/doi.org\/10.1073\/pnas.0501643102.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"9225_CR19","doi-asserted-by":"publisher","first-page":"4399","DOI":"10.1128\/JVI.01703-10","volume":"85","author":"CP Kung","year":"2011","unstructured":"Kung CP, Meckes DG Jr, Raab-Traub N. Epstein-Barr virus LMP1 activates EGFR, STAT3, and ERK through effects on PKCdelta. J Virol. 2011;85(9):4399\u2013408. https:\/\/doi.org\/10.1128\/JVI.01703-10.","journal-title":"J Virol"},{"issue":"11","key":"9225_CR20","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1373\/clinchem.2016.263624","volume":"62","author":"MB Johnson","year":"2016","unstructured":"Johnson MB, Flanagan SE, Martins TB, Hill HR, Hattersley AT, McDonald TJ. Low IgE is a useful tool to identify STAT3 gain-of-function mutations. Clin Chem. 2016;62(11):1536\u20138. https:\/\/doi.org\/10.1373\/clinchem.2016.263624.","journal-title":"Clin Chem"},{"issue":"17","key":"9225_CR21","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1182\/blood-2011-11-392985","volume":"119","author":"CS Ma","year":"2012","unstructured":"Ma CS, Avery DT, Chan A, et al. Functional STAT3 deficiency compromises the generation of human T follicular helper cells. Blood. 2012;119(17):3997\u20134008. https:\/\/doi.org\/10.1182\/blood-2011-11-392985.","journal-title":"Blood"},{"issue":"8","key":"9225_CR22","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1038\/icb.2012.17","volume":"90","author":"SA Diehl","year":"2012","unstructured":"Diehl SA, Schmidlin H, Nagasawa M, Blom B, Spits H. IL-6 triggers IL-21 production by human CD4+ T cells to drive STAT3-dependent plasma cell differentiation in B cells. Immunol Cell Biol. 2012;90(8):802\u201311. https:\/\/doi.org\/10.1038\/icb.2012.17.","journal-title":"Immunol Cell Biol"},{"issue":"2","key":"9225_CR23","doi-asserted-by":"crossref","first-page":"821","DOI":"10.4049\/jimmunol.162.2.821","volume":"162","author":"T Hiroi","year":"1999","unstructured":"Hiroi T, Yanagita M, Iijima H, et al. Deficiency of IL-5 receptor alpha-chain selectively influences the development of the common mucosal immune system independent IgA-producing B-1 cell in mucosa-associated tissues. J Immunol. 1999;162(2):821\u20138.","journal-title":"J Immunol"},{"issue":"12","key":"9225_CR24","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1093\/intimm\/dxp102","volume":"21","author":"T Kouro","year":"2009","unstructured":"Kouro T, Takatsu K. IL-5- and eosinophil-mediated inflammation: from discovery to therapy. Int Immunol. 2009;21(12):1303\u20139. https:\/\/doi.org\/10.1093\/intimm\/dxp102.","journal-title":"Int Immunol"},{"issue":"8","key":"9225_CR25","doi-asserted-by":"publisher","first-page":"463","DOI":"10.2183\/pjab.87.463","volume":"87","author":"K Takatsu","year":"2011","unstructured":"Takatsu K. Interleukin-5 and IL-5 receptor in health and diseases. Proc Jpn Acad Ser B Phys Biol Sci. 2011;87(8):463\u201385. https:\/\/doi.org\/10.2183\/pjab.87.463.","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"issue":"1","key":"9225_CR26","doi-asserted-by":"publisher","first-page":"5","DOI":"10.4049\/jimmunol.182.1.5","volume":"182","author":"J Stavnezer","year":"2009","unstructured":"Stavnezer J, Kang J. The surprising discovery that TGF beta specifically induces the IgA class switch. J Immunol. 2009;182(1):5\u20137. https:\/\/doi.org\/10.4049\/jimmunol.182.1.5.","journal-title":"J Immunol"},{"issue":"4","key":"9225_CR27","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/s1074-7613(00)00044-3","volume":"13","author":"BB Cazac","year":"2000","unstructured":"Cazac BB, Roes J. TGF-beta receptor controls B cell responsiveness and induction of IgA in vivo. Immunity. 2000;13(4):443\u201351. https:\/\/doi.org\/10.1016\/s1074-7613(00)00044-3.","journal-title":"Immunity"},{"issue":"3","key":"9225_CR28","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1684\/ecn.2019.0434","volume":"30","author":"Y Bagheri","year":"2019","unstructured":"Bagheri Y, Babaha F, Falak R, et al. IL-10 induces TGF-\u03b2 secretion, TGF-\u03b2 receptor II upregulation, and IgA secretion in B cells. Eur Cytokine Netw. 2019;30(3):107\u201313. https:\/\/doi.org\/10.1684\/ecn.2019.0434.","journal-title":"Eur Cytokine Netw"},{"issue":"12","key":"9225_CR29","doi-asserted-by":"publisher","first-page":"3928","DOI":"10.3390\/ijms19123928","volume":"19","author":"E Tamayo","year":"2018","unstructured":"Tamayo E, Alvarez P, Merino R. TGF\u03b2 superfamily members as regulators of B cell development and function-implications for autoimmunity. Int J Mol Sci. 2018;19(12):3928. https:\/\/doi.org\/10.3390\/ijms19123928.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"9225_CR30","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s00535-017-1350-1","volume":"52","author":"S Ihara","year":"2017","unstructured":"Ihara S, Hirata Y, Koike K. TGF-\u03b2 in inflammatory bowel disease: a key regulator of immune cells, epithelium, and the intestinal microbiota. J Gastroenterol. 2017;52(7):777\u201387. https:\/\/doi.org\/10.1007\/s00535-017-1350-1.","journal-title":"J Gastroenterol"},{"issue":"11","key":"9225_CR31","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1002\/eji.201746961","volume":"47","author":"CB Geier","year":"2017","unstructured":"Geier CB, Kraupp S, Bra D, et al. Reduced numbers of circulating group 2 innate lymphoid cells in patients with common variable immunodeficiency. Eur J Immunol. 2017;47(11):1959\u201369. https:\/\/doi.org\/10.1002\/eji.201746961.","journal-title":"Eur J Immunol"},{"issue":"6","key":"9225_CR32","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1002\/eji.201848006","volume":"49","author":"T Hochd\u00f6rfer","year":"2019","unstructured":"Hochd\u00f6rfer T, Winkler C, Pardali K, Mj\u00f6sberg J. Expression of c-Kit discriminates between two functionally distinct subsets of human type 2 innate lymphoid cells. Eur J Immunol. 2019;49(6):884\u201393. https:\/\/doi.org\/10.1002\/eji.201848006.","journal-title":"Eur J Immunol"},{"issue":"3","key":"9225_CR33","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.pai.0000173054.83414.22","volume":"13","author":"M Miettinen","year":"2005","unstructured":"Miettinen M, Lasota J. KIT (CD117): a review on expression in normal and neoplastic tissues, and mutations and their clinicopathologic correlation. Appl Immunohistochem Mol Morphol. 2005;13(3):205\u201320. https:\/\/doi.org\/10.1097\/01.pai.0000173054.83414.22.","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"8","key":"9225_CR34","doi-asserted-by":"publisher","first-page":"5956","DOI":"10.1074\/jbc.M110.182642","volume":"286","author":"A Chaix","year":"2011","unstructured":"Chaix A, Lopez S, Voisset E, Gros L, Dubreuil P, De Sepulveda P. Mechanisms of STAT protein activation by oncogenic KIT mutants in neoplastic mast cells. J Biol Chem. 2011;286(8):5956\u201366. https:\/\/doi.org\/10.1074\/jbc.M110.182642.","journal-title":"J Biol Chem"},{"issue":"2","key":"9225_CR35","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1084\/jem.20131128","volume":"211","author":"JY Shin","year":"2014","unstructured":"Shin JY, Hu W, Naramura M, Park CY. High c-Kit expression identifies hematopoietic stem cells with impaired self-renewal and megakaryocytic bias. J Exp Med. 2014;211(2):217\u201331. https:\/\/doi.org\/10.1084\/jem.20131128.","journal-title":"J Exp Med"},{"key":"9225_CR36","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41389-019-0148-9","volume":"8","author":"C Larrue","year":"2019","unstructured":"Larrue C, Heydt Q, Saland E, et al. Oncogenic KIT mutations induce STAT3-dependent autophagy to support cell proliferation in acute myeloid leukemia. Oncogenesis. 2019;8:39. https:\/\/doi.org\/10.1038\/s41389-019-0148-9.","journal-title":"Oncogenesis"},{"issue":"2","key":"9225_CR37","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1067\/mjd.2001.112221","volume":"44","author":"KA Richards","year":"2001","unstructured":"Richards KA, Fukai K, Oiso N, Paller AS. A novel KIT mutation results in piebaldism with progressive depigmentation. J Am Acad Dermatol. 2001;44(2):288\u201392. https:\/\/doi.org\/10.1067\/mjd.2001.112221.","journal-title":"J Am Acad Dermatol"},{"key":"9225_CR38","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/689756","volume":"2013","author":"YJ Yang","year":"2013","unstructured":"Yang YJ, Zhao R, He XY, et al. A novel splicing mutation of KIT results in piebaldism and auburn hair color in a Chinese family. Biomed Res Int. 2013;2013: 689756. https:\/\/doi.org\/10.1155\/2013\/689756.","journal-title":"Biomed Res Int"},{"issue":"3\u20134","key":"9225_CR39","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3109\/10428190009089427","volume":"37","author":"SF van Eeden","year":"2000","unstructured":"van Eeden SF, Terashima T. Interleukin 8 (IL-8) and the release of leukocytes from the bone marrow. Leuk Lymphoma. 2000;37(3\u20134):259\u201371. https:\/\/doi.org\/10.3109\/10428190009089427.","journal-title":"Leuk Lymphoma"},{"key":"9225_CR40","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1471-2334-8-28","volume":"8","author":"M Diepold","year":"2008","unstructured":"Diepold M, Noellke P, Duffner U, Kontny U, Berner R. Performance of Interleukin-6 and Interleukin-8 serum levels in pediatric oncology patients with neutropenia and fever for the assessment of low-risk. BMC Infect Dis. 2008;8:28. https:\/\/doi.org\/10.1186\/1471-2334-8-28.","journal-title":"BMC Infect Dis"},{"issue":"6","key":"9225_CR41","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1006\/cyto.1999.0664","volume":"12","author":"YV Chaly","year":"2000","unstructured":"Chaly YV, Selvan RS, Fegeding KV, Kolesnikova TS, Voitenok NN. Expression of IL-8 gene in human monocytes and lymphocytes: differential regulation by TNF and IL-1. Cytokine. 2000;12(6):636\u201343. https:\/\/doi.org\/10.1006\/cyto.1999.0664.","journal-title":"Cytokine"},{"issue":"6","key":"9225_CR42","doi-asserted-by":"publisher","first-page":"9035","DOI":"10.3892\/mmr.2017.7747","volume":"16","author":"Y Guo","year":"2017","unstructured":"Guo Y, Zang Y, Lv L, et al. IL-8 promotes proliferation and inhibition of apoptosis via STAT3\/AKT\/NF-\u03baB pathway in prostate cancer. Mol Med Rep. 2017;16(6):9035\u201342. https:\/\/doi.org\/10.3892\/mmr.2017.7747.","journal-title":"Mol Med Rep"},{"issue":"1","key":"9225_CR43","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3390\/ijms20010098","volume":"20","author":"T Zheng","year":"2018","unstructured":"Zheng T, Ma G, Tang M, Li Z, Xu R. IL-8 Secreted from M2 macrophages promoted prostate tumorigenesis via STAT3\/MALAT1 pathway. Int J Mol Sci. 2018;20(1):98. https:\/\/doi.org\/10.3390\/ijms20010098.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"9225_CR44","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1186\/s13046-019-1310-0","volume":"38","author":"J Wu","year":"2019","unstructured":"Wu J, Gao FX, Wang C, et al. IL-6 and IL-8 secreted by tumour cells impair the function of NK cells via the STAT3 pathway in oesophageal squamous cell carcinoma. J Exp Clin Cancer Res. 2019;38(1):321. https:\/\/doi.org\/10.1186\/s13046-019-1310-0.","journal-title":"J Exp Clin Cancer Res"},{"issue":"6","key":"9225_CR45","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.7150\/thno.15625","volume":"7","author":"H Ha","year":"2017","unstructured":"Ha H, Debnath B, Neamati N. Role of the CXCL8-CXCR1\/2 axis in cancer and inflammatory diseases. Theranostics. 2017;7(6):1543\u201388. https:\/\/doi.org\/10.7150\/thno.15625.","journal-title":"Theranostics"},{"key":"9225_CR46","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.ijbiomac.2018.05.121","volume":"117","author":"N Fathi","year":"2018","unstructured":"Fathi N, Rashidi G, Khodadadi A, Shahi S, Sharifi S. STAT3 and apoptosis challenges in cancer. Int J Biol Macromol. 2018;117:993\u20131001. https:\/\/doi.org\/10.1016\/j.ijbiomac.2018.05.121.","journal-title":"Int J Biol Macromol"},{"issue":"3","key":"9225_CR47","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.clim.2013.01.004","volume":"146","author":"K Goudy","year":"2013","unstructured":"Goudy K, Aydin D, Barzaghi F, et al. Human IL2RA null mutation mediates immunodeficiency with lymphoproliferation and autoimmunity. Clin Immunol. 2013;146(3):248\u201361. https:\/\/doi.org\/10.1016\/j.clim.2013.01.004.","journal-title":"Clin Immunol"},{"issue":"3","key":"9225_CR48","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/nri3156","volume":"12","author":"O Boyman","year":"2012","unstructured":"Boyman O, Sprent J. The role of interleukin-2 during homeostasis and activation of the immune system. Nat Rev Immunol. 2012;12(3):180\u201390. https:\/\/doi.org\/10.1038\/nri3156.","journal-title":"Nat Rev Immunol"},{"issue":"11","key":"9225_CR49","doi-asserted-by":"publisher","first-page":"7593","DOI":"10.4049\/jimmunol.179.11.7593","volume":"179","author":"JR Pallandre","year":"2007","unstructured":"Pallandre JR, Brillard E, Cr\u00e9hange G, et al. Role of STAT3 in CD4+CD25+FOXP3+ regulatory lymphocyte generation: implications in graft-versus-host disease and antitumor immunity. J Immunol. 2007;179(11):7593\u2013604. https:\/\/doi.org\/10.4049\/jimmunol.179.11.7593.","journal-title":"J Immunol"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-021-09225-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12026-021-09225-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-021-09225-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,7]],"date-time":"2023-01-07T10:52:47Z","timestamp":1673088767000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12026-021-09225-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,14]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["9225"],"URL":"https:\/\/doi.org\/10.1007\/s12026-021-09225-0","relation":{},"ISSN":["0257-277X","1559-0755"],"issn-type":[{"value":"0257-277X","type":"print"},{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,14]]},"assertion":[{"value":"12 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Research Ethics Committee University of Campinas (UNICAMP), No. 1176\/2011.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All participants gave informed written consent according to the Research Ethics Committee University of Campinas (UNICAMP).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All authors reviewed and approved this manuscript for publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}